期刊
THERANOSTICS
卷 11, 期 4, 页码 1753-1762出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.53438
关键词
Pancreatic cancer; Hippo pathway; YAP; KRAS; therapeutic target
资金
- National Natural Science Foundation of China [81874188, 31501123]
- Key R&D and promotion projects of Henan province [202102310119]
This review explores the oncogenic role and regulatory mechanism of YAP in PDAC, highlighting its potential as a therapeutic target in various human cancers.
Pancreatic cancer, especially pancreatic ductal adenocarcinoma (PDAC), remains a fatal disease with few efficacious treatments. The Hippo signaling pathway, an evolutionarily conserved signaling module, plays critical roles in tissue homeostasis, organ size control and tumorigenesis. The transcriptional coactivator yes-associated protein (YAP), a major downstream effector of the Hippo pathway, is associated with various human cancers including PDAC. Considering its importance in cancer, YAP is emerging as a promising therapeutic target. In this review, we summarize the current understanding of the oncogenic role and regulatory mechanism of YAP in PDAC, and the potential therapeutic strategies targeting YAP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据